Supply Chain Intelligence

Fennec Pharmaceuticals Inc. Supply Chain

FENC supply chain intelligence for Fennec Pharmaceuticals Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

FENC ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
3Customers
2Debt Items
20Related Chains

Fennec Pharmaceuticals Inc. Suppliers

TickerNameConfidenceEvidence
INPHARMUS INPHARMUS 85% Our strategy depends in part on the efforts of third party development partners to obtain regulatory approvals and commercialize PEDMARK ® outside the United States, including Norgine in Europe and I…
ORANY ORANY 72% y would be the case if we were to manufacture our product. Further, the third parties we deal with could have staffing difficulties, might undergo changes in priorities or may become financially dist…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from FENC graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from FENC graph: y would be the case if we were to…

Fennec Pharmaceuticals Inc. Customers

TickerNameConfidenceEvidence
THIRD-PARTY-THAT-ADMINISTERS-THE-COPAY-PROGRAM THIRD-PARTY-THAT-ADMINISTERS-THE-COPAY-PROGRAM 75% The Company accrues a liability for co-payment assistance based on actual program participation and estimates of program redemption using customer data provided by the third party that administers th…
ORANY ORANY 72% ained in the Orphan Drug Act has been the subject of recent scrutiny from the press, from some members of Congress and from some in the medical community. Furthermore, the FDA’s interpretations of th…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from FENC graph: ained in the Orphan Drug Act has been the subject of recent scrutiny from the press, from some members of Congress a…

Fennec Pharmaceuticals Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
FENC-DEBT-9472 Warrants outstanding: 8 90% xbrl warrant detail from xbrl 2025-09-30.
FENC-DEBT-9473 Xbrl Convertible 90% xbrl convertible detail from xbrl 2013-12-31.

Fennec Pharmaceuticals Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Fennec Pharmaceuticals Inc..

Fennec Pharmaceuticals Inc. Ownership

HolderNameConfidenceEvidence
FENC-OWNER-ROSALIND-ADVISORS-INC Rosalind Advisors, Inc. 90% 13F overlay lists Rosalind Advisors, Inc. as top holder; 91 tracked holders.

Fennec Pharmaceuticals Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['customer', 'supplier']
AMZE Amaze Holdings, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CORT Corcept Therapeutics Incorporated 50.00 2
BSBK Bogota Financial Corp. 50.00 2
BLTE Belite Bio, Inc 50.00 2
View FENC supply chain intel →

Explore the full interactive supply chain map for Fennec Pharmaceuticals Inc..

Open FENC supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map